Pomdoctor (POM) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$60.1M

Revenue (quarter)

$27.3M

Revenue growth (year over year)

+11.95%

Gross profit (trailing twelve months)

$7.2M

Gross margin

12.06%

Net income (trailing twelve months)

−$51.0M

Net income (quarter)

−$35.1M

Net income growth (year over year)

−1164.52%

Net margin

−84.94%

Return on equity

—

EPS (trailing twelve months)

−$169.16

Book value per share

−$8.97

P/E (trailing twelve months)

—

Price to book

—

Debt to assets

764.94%

Payout ratio

—

Dividend yield

—

Company profile

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

• Is Pomdoctor (POM) profitable?

  No. Pomdoctor reported a net loss of $51.0M over the trailing twelve months.

• How much revenue does Pomdoctor (POM) make?

  Pomdoctor generated $60.1M in revenue over the trailing twelve months, up 11.95% year over year.

• How do I buy stock in Pomdoctor (POM)?

  POM trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.